T-PLL-1 protocol of the German CLL study group (GCLLSG) - A prospective phase II trial of fludarabine phosphate, mitoxantrone and cyclophosphamide (FMC) followed by alemtuzumab consolidation in T-PLL.

Dokumenttyp:: Meeting Abstract
Autor(en):: Hopfinger, G; Busch, R; Eichhorst, B; Kandler, G; Wendtner, C; Hallek, M
Titel:: T-PLL-1 protocol of the German CLL study group (GCLLSG) - A prospective phase II trial of fludarabine phosphate, mitoxantrone and cyclophosphamide (FMC) followed by alemtuzumab consolidation in T-PLL.
Zeitschriftentitel:: Blood
Jahr:: 2005
Band / Volume:: 106
Heft / Issue:: 11
Seitenangaben Beitrag:: 602A-603A
Sprache:: eng
Print-ISSN:: 0006-4971
TUM Einrichtung:: Institut für Medizinische Statistik und Epidemiologie
BibTeX

Vorkommen: